23/03/2026
As proud supporters of the RCD Foundation, we wanted to share a truly extraordinary milestone.
In February, the RCD Foundation marked a world first with the launch of PaedNEO-VAX, a world-first Australian clinical trial testing personalised mRNA cancer vaccines for children and adolescents with advanced or treatment-resistant brain tumours.
This trial is the result of years of dedicated research, supported by the RCD Foundation and their remarkable community, moving promising science out of the lab and into real clinical care for children who urgently need better options.
We are proud to support the RCD Foundation and the incredible work they do.
Learn more about the trial: https://bit.ly/mrna-trial